Sungkyunkwan University · 医学
Professor Jung Wook Huh's research lab specializes in colorectal cancer oncology, focusing on prognostic biomarkers, surgical outcomes, and pathological predictors of recurrence and survival. The lab investigates preoperative serum markers like CEA, lymph node metastasis distribution, and imaging modalities such as ERUS and CT to improve treatment response prediction. Key research directions include identifying clinicopathological factors influencing pathological complete response and evaluating the impact of complications like anastomotic leakage on long-term oncologic outcomes. The lab also explores molecular markers such as CD44s to understand their role in tumor progression and patient prognosis.
Figures are computed from collected data and may differ slightly.
Preoperative serum CEA is a reliable predictor of recurrence and survival after curative surgery in patients with colon cancer, particularly in those classified as having stage II disease.
Anastomotic leakage (AL) is one of the most serious complications of colorectal surgery. It can affect long-term oncologic outcomes, but the impact on long-term survival remains uncertain. The aim of this study is to evaluate the operative characteristics of leakage and no leakage groups and to analyze long-term oncologic outcomes. We prospectively enrolled 10,477 patients from 2000 to 2011 and retrospectively reviewed the data. Male sex (odds ratio [OR], 3.90; P < 0.001), intraoperative transfu
In Brief Objective: This study evaluated the prognostic significance of the distribution of lymph node metastases (LND) in patients with colorectal cancer. Background: The impact of the LND on survival in colorectal cancer is unknown. Methods: A total of 1205 consecutive patients who underwent potentially curative surgery for sigmoid colon or rectal cancer with high ligation of the inferior mesenteric artery (IMA) from January 1997 to February 2008 were assigned to 4 groups based on LND: LND0, n
Pretreatment clinical variables, including tumor circumferentiality, macroscopic ulceration, and CEA level, may be important determinants in achieving a pathological complete response.
ERUS and CT may allow good prediction of node-negative rectal cancers, although they are inaccurate modalities for predicting treatment response on the rectal wall. New methods of interpretation and diagnostic criteria for ERUS and CT are essential for increasing the accuracy of cancer prediction in at-risk patients.
The aim of the present study was to evaluate the expression of standard CD44 (CD44s) in colorectal cancer (CRC), its relationship with clinicopathological characteristics, and its potential prognostic significance. CD44s levels were measured on immunohistochemistry in tumors and surrounding normal mucosa from 74 patients with primary colorectal carcinomas. The patients were followed for a median period of 37 months. Expression of CD44s in primary tumor and surrounding normal mucosa tissues was d
A circumferential resection margin of ≤1 mm had a strong association with disease-free survival compared with circumferential resection margins ≤0.5, ≤2.0, and ≤3 mm. A circumferential resection margin ≤1 mm was an independent predictor of a poor outcome in both the nonchemoradiotherapy and chemoradiotherapy groups.
Elevated CD44 mRNA levels in pretreatment biopsies might be predictive of poor tumor regression after preoperative chemoradiation in rectal cancer. Moreover, the proliferating cell nuclear antigen mRNA level might be predictive of nodal regression.
The FDG-PET/CT parameters, and especially the RI, may be best for assessing the neoadjuvant chemoradiation response of locally advanced rectal cancer and these values can potentially assist physicians for planning the optimal treatment.
Abstract Background The potential advantage of adjuvant chemotherapy in patients with ypT0‐2N0 rectal cancer remains unclear. The purpose of this study was to evaluate whether this therapy has an impact on survival. Materials and Methods Patients who underwent curative surgery after preoperative chemoradiation for locally advanced low rectal cancer were retrospectively reviewed. A total of 41 consecutive patients with pathological stage 0 (ypT0N0) or I (ypT1‐2N0) were enrolled. Of the 41 patient
Open papers in the app to read, cite, and organize with AI.